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Growing gastrointestinal (GI) research program at Baystate
Gastrointestinal (GI)
research is a burgeoning
field in western Massachusetts. Currently,
Baystate Health has 12 GI
physicians, three advanced
providers, and six GI
fellows and residents. Dr.
Rohit Singhania, Director of
Clinical Research (Department of Gastroenterology)
at Baystate Medical Center,
believes GI research has
a great future at Baystate.
His primary goal is to create an outpatient inflammatory bowel disease (IBD)
clinic that serves patients
with Crohn’s disease and
Ulcerative Colitis through
care and therapy.

“We want to improve
the care of our GI patients
and provide access to
investigational therapies,”
said Dr. Singhania. “We
are collaborating with our
GI physicians at Baystate
to identify how we can
improve care for our
patients.” This includes
three major funded official
programs so far:
1. YELLOWSTONE trial –
Phase 3, Multicenter, Randomized, Double Blinded,
Placebo-Controlled Study
of Oral Ozanimod as Induction Therapy, Maintenance
Therapy and Open-Label
Extension For Moderately
to Severely Active Crohn’s

Disease. (Sponsor: Celgene, now Bristol Meyers
Squibb Inc.)
2. QUASAR Trial: A
Study of the Efficacy and
Safety of Guselkumab in
Participants with Moderately to Severely Active
Ulcerative Colitis Protocol
CNTO1959UCO3001.
(Sponsor: Janssen Research and
Development)
3. Alliance for IBD
(All4IBD): A Digital QI
network for Inflammatory
Bowel Disease with a goal
to improve outcomes for
patients through digital
patient engagement – to
enhance patient-provider

Rohit Singhania, MD, MS,
FACG, AGAF

engagement, provide
patient education, perform
remote patient monitoring,
and support integrated
patient care using the
Rx.Health IBD Digital
Medicine Toolkit that can

Judith Pride, RN, MSHS, CCRC,
CRP, CIP

be “prescribed” directly
to patient smartphones.
(Sponsored by Roche and
Rx.Health)
Other recent efforts to
aid GI patients are through
(Continued on page 2)

Clinical Trials Unit (CTU) introduces Clinical Trial Specialist
The CTO is pleased to
welcome Viorika Nelson,
DNP, FNP-C, Clinical Trial
Specialist. The Clinical Trial
Specialist (CTS) is responsible for assisting the PIs
in directing the care of
subjects enrolled in clinical
trials and has a significant
role in the conduct of
research. Dr. Nelson will
work collaboratively with
the PIs and other health
care team members such
as a sub-investigator on
various clinical trials. She
is working at the new

Clinical Trials Unit, located
at 80 Wason Avenue in
Springfield.
“There is a vast need
for this role,” said Judy
Pride, Judith Pride, RN,
MSHS, CCRC, CCRP, CIP,
Program Director of the
Clinical Trials Office. “The
CTU is located offsite from
the main Baystate campus
and 3300 Main Street. Our
investigators have competing responsibilities, which
makes it more difficult to
attend each participant
study visit. The CTS will

be available to complete
required study activities in
the absence of the PI.”
Dr. Nelson will assist with
physical exams, reviewing lab results, monitoring
patients, consenting study
participants, and various
protocol required study
assessments. She began
working for Baystate
in 2001 as a registered
nurse on the surgical floor.
Since then, she has held
other roles in cardiology,
psychiatry, and substance
abuse as a NP. On top

of this, she has a diverse
background and is multilingual in English, Romanian, and Russian. She has
always had an interest in
teaching and/or research
and is excited to be the first
to take on this new role.
“[I am learning that] there
are lots of protocols, ensuring safety for the patients,
confidentiality for the
patients, and the ins and
outs of the different trials,”
explained Dr. Nelson.
“I think she will be
a great addition to our

Research Question? Call the Office of Research at our central number: 413-794-3391

Viorika Nelson, DNP, FNP-C, is
the new Clinical Trial Specialist
at 80 Wason Avenue.

team. It is important to
have a diverse team to
help contribute to diverse
(Continued on page 2)
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What is nursing research? And why is it so important?
Nursing is often
described as an art. Within
that art, the layperson may
see it as a series of tasks:
checking in with patients,
ensuring they get their
medications, and more.
As with other practice
professions, nursing, is in
fact, quite heavily based
in science and research.
Sometimes this gets
lost because of the past
perceptions of nursing as
a task-oriented profession.
In 2020, the Year of the
Nurse and Midwife, we
celebrated the birth of the
first known nurse scientist:
Florence Nightingale. Her
theories still provide the
foundation for much of
nursing practice.
Nursing research
seeks to evaluate nursing
practice and test theories
and models of nursing
practice to find answers

to questions relating to
nursing interventions,
education, workforce
trends, and healthcare
delivery with a goal of
providing the foundation for evidence-based
solutions.
Melissa O’Malley
Tuomi, PHD, RN, CPHQ is
the Director of Professional Practice, Nursing
Quality, and Research at
Baystate Medical Center
and an Assistant Professor at UMass Medical
Graduate School of
Nursing (GSN). She leads
the newly-established
Center for Nursing Excellence and Innovation,
which oversees nursing
practice, professional
development, and research
and also serves as a bridge
between the Baystate
Institutional Review Board
(IRB) and nurses and

Melissa O’Malley Tuomi, PHD, RN,
CPHQ is the Director of Professional
Practice, Nursing Quality, and
Research at Baystate Medical
Center and an Assistant Professor
at UMassMedical Graduate School
of Nursing (GSN).

students. Her favored
research method to teach
is “qualitative descriptive,”
an inductive and subjective
process used throughout
healthcare to capture data
through interviews, focus
groups, observations, or

documents to explore the
“lived [human] experience” of the phenomenon being studied. The
method takes an emic
stance to provide rich
description through the
eyes of the participant.
Data obtained through
this method is rigorously
reviewed to ensure
trustworthiness and provides the foundation for
more complex quantitative analysis and, in Dr.
Tuomi’s case, instrument
development to measure
the effect of our work on
outcomes.
“Nursing research is
only about 170 years old,
and many of our interventions still need to be
studied,” said Dr. Tuomi.
“What we are trying to do is
to apply existing research
methods to answer
burning questions in

nursing practice. The way
I describe this to nurses
is: ‘what is the thing you
often wonder about or find
frustrating in practice?’”
While many nurses are
intrigued by research,
some find themselves
frustrated with the process.
“A bachelor’s degree
alone doesn’t prepare you
for research entirely, but
it provides a solid start. In
the 2011 IOM report ‘The
Future of Nursing: Leading Change, Advancing
Health,’ Dr. Don Berwick
posits that nurses are well
poised to lead improvement based on their
education,” explained Dr.
Tuomi. “The practice of
nursing research requires
advanced training in
methods and knowledge
of human rights and
etc. We are building a
(Continued on page 3)

COVID therapies after a year of research efforts - Mark Tidswell, MD
I am fortunate to work in
the Critical Care research
program at Baystate.
We have been funded
by the NIH for the past
twenty years as a center
in a US network for a Lung
Injury research. Last year,
this NIH network was
ideally poised to carry
out research on severe
COVID-19. We now run
several Federal operation
warp speed trials to evaluate new therapies, and we
conduct CDC surveillance
work. The pace of COVID19 research is rapid. Almost
as quickly as a new therapy is available, it is added

to one of our trials. Dr. Jay
S. Steingrub oversees
this research at Baystate,
Brigham and Women’s
Hospital, Maine Medical
Center, and University
of Florida Health. Under
his direction, the staff of
the Critical Care research
program are constantly at
work and have enrolled
hundreds of subjects here
at Baystate. The effort
requires late nights and
weekends and is helping
to find better treatments for
patients with COVID-19. We
have expanded our work
to patients on the ward
as well as in the ICU. The

(Continued from page 1)

in 2021, beginning with
Crohn’s Disease (Yellowstone) and Ulcerative
Colitis (Quasar),” said Judith
Pride, RN, MSHS, CCRC,
CRP, CIP, Program Director
of the Baystate Clinical
Trials Office (CTO). “The
CTO will be instrumental in
the conduct of the trials by
providing study coordination, regulatory services,
helping enroll patients and
complete study visits.” The

the COVID-19 registry with
Dr. Mihaela Stefan, as well
as several resident projects
submitted for publication or
as posters (with a Presidential Poster Award from
the American College of
Gastroenterology’s annual
meeting in 2020).
Clinical Trials for GI
“We’re planning on
opening our first GI studies

research team includes
Lesley DeSouza, Sherrell Thornton-Thompson,
Cynthia Kardos, RN, Sarah
Romain, RN, and Lori-Ann

Kozikowski, RN, all of
whom have worked hard
through the surges of
COVID-19. We also have
support from the Baystate
Clinical Trial Office: Scott
Oeullette, Andres Santana,
and others.
Last year Anthony Fauci
said “you’re not just going
to pull a vaccine out of
your pocket”, because we
usually expect vaccine
development to take many
years. Yet, not even a year
later, millions of people
in the US have been vaccinated. We also have new
therapies proven to be
effective to treat COVID-19.

The astonishing and rapid
progress in research is
due to international collaboration, public funding,
attention to safety, and the
incredible effort of clinical
researchers. It is also a
tribute to the courage of
people who volunteer as
research subjects.
Although this past year
has been difficult, I am
grateful to work with a
research group at Baystate
that contributes to the
worldwide goal of finding
solutions to COVID-19.
Hopefully these efforts
will speed up our return to
normal.

studies were planned to
launch in 2020 but were
delayed due to the impact
of COVID-19. Mrs. Pride
added “we have hired a
Clinical Trial Specialist (AP)
position to assist our investigators fulfill day to day
study activities. The Clinical
Trial Specialist joined our
team in March.”
“Obviously, these efforts
could not have been initiated without the blessings,

guidance, and mentorship of Dr. Ira Schmelkin
(Division Chief, GI), Dr.
Abraham Thomas (Chair,
Department of Medicine),
Dr. Peter Friedmann, Dr.
Jay Steingrub, Dr. David
J. Desilets, and the entire
team of Baystate Gastroenterology,” added Dr.
Singhania. “Through these
efforts, we have been able
to distinguish Baystate on
the forefront of GI care.”

(Continued from page 1)

Mark Tidswell, MD

enrollment in our clinical
trials.” added Mrs. Pride.
Fun facts: Dr. Nelson
loves her rescue dog
(German Shepherd-Lab
mix), her family, and
her husband, who is
a physical therapist at
Baystate. She enjoys
hiking and biking and
being outdoors.

(Continued from page 2)

team of mentors with
this advanced training to
support nurses looking to
become more involved
in conducting research
to answer their own
questions.”
The National Institute of
Nursing Research (NINR),
part of the National
Institutes for Health (NIH),
defines nursing research
as “developing knowledge to build the scientific foundation for clinical
practice, prevent disease
and disability, manage
and eliminate symptoms
caused by illness, and
enhance end-of-life and
palliative care.”
“Nurses don’t always
realize that they are ‘scientists at work’ [Berwick,
2011] but all day long we
are asking questions and
answering them with data
in a systematic way. For
example, you’re applying existing knowledge
to test a hypothesis
every time you assess
someone with low blood
pressure and increase
their IV fluids as opposed

to giving medication. I
teach students that the
nursing process (Assess,
Diagnose, Plan, Intervene,
Evaluate) is similar to
improvement methods
and the scientific process,” added Dr. Tuomi.
Research and quality improvement go
hand-in-hand.
“An important part of
our care is spending uninterrupted time at the bedside listening to patients,”
said Dr. Tuomi. “From their
stories, we learn so much
about the social context
of their illness and patient
experience and can gain
insight into ways to help
them heal or transition to
the next step in their care.
I want to bring methods
like this to more of our
nurses so they realize
that research isn’t a big,
scary thing; it’s grounded
in a key function of nursing: observing. There are
some nurses that love
research, and we want to
foster that.”
Each year, Dr. Tuomi
and her team present “Art
of Innovation.” This event

celebrates research
and improvement in
nursing and presents an
opportunity for nurses
to showcase their work
and learn about ways to
become involved. She
and Dr. Paulette SeymourRoute, PhD, RN, the
Nurse Scientist at BMC,
are currently conducting
an instrument development study to assess
the impact of certain job
characteristics on nurses’
job satisfaction.
This year (2021), Dr.
Tuomi and her team are
hoping to launch a mentorship program and work
with nurses interested in
asking questions about
what they do.
“Healthcare is changing, and nurses need to
be equal partners with
other healthcare professions in leading change.
One goal of the BMC
Center of Nursing Excellence and Innovation is
to help retain nurses by
better understanding the
work that they do and
how that influences their
perception of nursing.”

News from Tufts CTSI
THE 23RD ANNUAL
CLINICAL AND
TRANSLATIONAL
SCIENCE GRADUATE
PROGRAM SYMPOSIUM
IS FRIDAY, MAY 7
Interested in cuttingedge research conducted
by the next generation of
investigators? Join us for
the 23rd Annual Clinical
and Translational Science
(CTS) Graduate Program
Symposium on Friday,
May 7, 9:00AM-1:00PM,
via Zoom. This event will
feature presentations and
posters by CTS Graduate Program students,
as well as a keynote
address by Robert W. Yeh,

MD, MSc, MBA, Director
of the Richard A. and
Susan F. Smith Center
for Outcomes Research
in Cardiology at the Beth
Israel Deaconess Medical
Center, and Associate
Professor of Medicine at
Harvard Medical School.
Learn more at tuftsctsi.
org/events/23rd-annualclinical-and-translationalscience-graduate-program-symposium.
MENTOR TRAINING FOR
JUNIOR AND SENIOR
FACULTY
Want to have more
effective mentor/mentee relationships? Join

Tufts CTSI this spring
for training opportunities for faculty members
with mentees preparing
for research careers in
biomedical, behavioral,
clinical, and social sciences. Junior and senior
faculty are invited to
apply to attend Mentor
Training on Monday, May
17 or Monday, May 24,
1:00-3:00PM. Apply at
tufts.qualtrics.com/jfe/
form/SV_bqttGsyvfh1aEv4
by May 12.
Please contact Amy
West to register or with
any questions at awest@
tuftsmedicalcenter.org.

All aboard the
patient transport
vehicle!
(Left) Drs. Peter Vieira and Peter
Friedmann take the CTU’s patient
transport vehicle out for a spin. The
vehicle will take patients from other
main campus buildings to the CTU at
80 Wason Ave.
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Kudos
C3PO study on convalescent plasma treatment
for COVID-19 recognized
by NIH
With the C3PO outpatient convalescent plasma
study ending, Baystate
has distinguished itself as
one of the top enrollers
for this NIH funded
multicenter clinical trial
coordinated through the
SIREN network. The trial
was stopped in early 2021
for futility of detecting a
difference in the primary
outcome. Led by Howard
Smithline, MD and the
C3PO team. Well done!
Daniel Skiest, MD published in New England
Journal of Medicine
Congratulations to Dr.
Dan Skiest, Professor of
Medicine, on co-authoring
the New England
Journal of Medicine
publication “Tocilizumab

in Hospitalized Patients
with Severe Covid-19
Pneumonia.”
Dr. Bill Soares earns Honorable Mention for Best
Overall Abstract from
the American Society
of Addiction Medicine
(ASAM)
William Soares MD’s
recent abstract, “A
Qualitative Study of
Addiction Treatment State
Legislation in Emergency
Departments,” has been
selected to receive the
ASAM Abstract Submission Award Honorable
Mention: Best Overall. This
recognition is presented
to the primary author of a
very high scoring submitted abstract in that award
category. Dr. Soares will
present this abstract at the
ASAM Virtual Conference
2021. Congratulations!

Clinical trials unit planned for
Baystate Franklin Medical Center
The Office of Research
plans to develop a Clinical Trials Unit at Baystate
Franklin Medical Center.
Space has been identified
and plans are in the initial
phase. New developments

will be announced throughout the year.

Did you know? Clinical Trials Day is May 20
Clinical Trials Day falls
on May 20 every year.
It is a national day to
recognize clinical trials
staff, researchers, and the
history of clinical trials. It is
also a day to bring awareness to clinical trials and
pursuing clinical research
as a career option.
Baystate Health has
dozens of researchers and
research staff who explore
the unknown every day,
moving scientific and
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medical explorations
forward.
“We would like to use
Clinical Trials day to thank
all of our researchers and
clinical trials staff,” said
Judith Pride, RN, MSHS,
CCRC, CCRP, CIP, Program
Director of the Clinical
Trials Office (CTO) at
Baystate Health.
Learn more about the
history of Clinical Trials
Day at clinicaltrialsday.org/
about.

We are interested in ensuring that Baystate employees and patients (and their families)
are aware of the important research that goes on at Baystate and how it contributes to
better patient care. The Innovator welcomes feedback and story ideas. Contact Allison
Billeter at allison.billeter@baystatehealth.org to submit yours.
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Compliance Corner with Jennifer Pacheco, MPH, CIM, CIP
CIS Clinical Trial Alerts
Beginning April 2, 2021,
CIS alert request forms
are required with each
new sponsored clinical
trial submission to the
IRB. In an effort to close
gaps identified in the
organizations Clinical Trial
remediation overseen
by the Board of Trustees
Audit and Compliance
Committee, we must also
require current projects to
update and maintain CIS
alerts with linked patient
participants.

Studies without an
active CIS alert have been
identified. Sola Odesina,
HRPP Education and
Compliance Specialist, will
provide research teams
with a list of projects that
currently do not have a
CIS Alert and answer any
questions they have on
the form or process.
 he Florence eBinder
T
Suite is Live!
Baystate's new eBinder
suite went live March
15, 2021. All funded

projects and all internally
supported projects
requiring an expedited
or full board IRB review
will require use of the
system. To date several
training sessions have
been offered to assist
users in becoming
acquainted with the
system. Research teams
were provided a link to
training but if you need
us to resend please email
us at HumanResearch@
Baystatehealth.org.
The system is designed

News from UMass CCTS

as a digital version of
the regulatory paper
binder that enables our
teams to organize, store,
e-sign, and track research
documents for those
on-site and remote. It will
also assist with sponsor
remote monitor visits;
allow the study team
to access documents
between research
locations.
Please call 413-7943458 or email Jennifer.
Pacheco@baystatehealth.
org if you have questions.

Jennifer Pacheco, MPH, CIM,
CIP

Meet the Researcher
accessible and fun, and this is the
same excitement I try and pass along
to the residents I mentor now.

TRAINING OPPORTUNITIES
TO AUGMENT LEARNING
(TOTAL)
The DL&I Incubator team
is pleased to announce
the launch of Training
Opportunities To Augment
Learning (TOTAL), a digital
app that allows biomedical
trainees to attend career and
professional development
events held at Boston
University and eight Bostonbased partner institutions.
Learn more at digital.bu.edu/
total-qa.

PROJECTS IN PROCESS
SEMINAR SERIES (PIPSS)
Virtual event on Fridays,
through June 11, 11:00 AM
- 12:00 PM. The series will
feature presentations from
our TL1, Millennium, MSCI and
KL2 scholars on their various
research projects. Contact
Melissa Corash at Melissa.
BrewerCorash@umassmed.
edu for further details.

Contact Baystate’s Health Science Library for more information at libraryinfo.bhs.org/home

Zhou Y, O’Donovan B, Beqari J,
Alouidor R. Retroperitoneal Necrosis as
a Rare Complication After Celiac Plexus
Block. Cureus. 2021 Feb 6;13(2):e13169.
doi: 10.7759/cureus.13169.
Wormser GP, McKenna D, Shaffer KD,
Silverman JH, Scavarda C, Visintainer
P. Evaluation of selected variables
to determine if any had predictive
value for, or correlated with, residual
symptoms at approximately 12 months
after diagnosis and treatment of early
Lyme disease. Diagn Microbiol Infect
Dis. 2021 Feb 12;100(3):115348. doi:

Corina Schoen, MD

Name: Corina N. Schoen, MD
Title/Academic Rank: Assistant
Professor Obstetrics and Gynecology

Notable Recent Published Papers
Bhat AG, Farah M, Szalai H, Lagu T,
Lindenauer PK, Visintainer P, Pack
QR. Evaluation of the American
Association of Cardiovascular and
Pulmonary Rehabilitation Exercise
Risk Stratification Classification Tool
Without Exercise Testing. J Cardiopulm
Rehabil Prev. 2021 Feb 11. doi: 10.1097/
HCR.0000000000000584. Epub
ahead of print.

What is your area of research?
Labor, labor induction, preeclampsia,
and preterm labor.

10.1016/j.diagmicrobio.2021.115348. Epub
ahead of print.
Schoenfeld EM, Poronsky KE,
Westafer LM, DiFronzo BM, Visintainer
P, Scales CD, Hess EP, Lindenauer PK.
Feasibility and efficacy of a decision
aid for emergency department patients
with suspected ureterolithiasis: protocol
for an adaptive randomized controlled
trial. Trials. 2021 Mar 10;22(1):201. doi:
10.1186/s13063-021-05140-9.
Westafer LM, Bond C, Milne W. Diagnostic Testing Differences Between
Advanced Practice Providers and
Physicians. Acad Emerg Med. 2021 Mar
15. doi: 10.1111/acem.14247. Epub ahead
of print.
Artenstein AW. A half-century of
meningococcal vaccines. Vaccine.
2021 Mar 19:S0264-410X(21)00292-9.
doi: 10.1016/j.vaccine.2021.03.024. Epub
ahead of print.

Department: Ob-Gyn, Division of
Maternal Fetal Medicine
Number of years at Baystate: 4
What research training do you
have? I was fortunate enough to
do fellowship at a place where the
faculty were very active researchers.
There was mentorship throughout
my 3 years of subspecialty training in
clinical trial development and metaanalyses, with additional graduate
level courses to supplement this
training.
What got you interested in research
overall? I never thought I would be
doing what I do today. I very much
went into Maternal Fetal Medicine for
the clinical practice, but my mentor
in fellowship made research so

Do you have any awards? I
am currently receiving funding
through the RPAP for a single
arm observational trial looking at
induction of labor at term to reduce
the cesarean delivery rate for women
with obesity. I am also awaiting
comments for an RO1 submitted
with Yale to assess the prematurity
and fetal growth restriction risk
associated with marijuana use during
pregnancy.
What do you like most about your
job? I love the variety in my work. I
get to teach residents every day, and
for the select few who are preparing
for fellowship I get to serve as a
close mentor, and this often persists
well after graduation. Clinically my
work is extremely rewarding, and
my best days are those where I can
provide reassurance to women with
the most complicated pregnancies.
I find my research is applicable
to many of the patients I treat,
and instituting practice-changing
management based on my research
trials conducted at Baystate has
fueled my drive to keep going.
What do you do to unwind
outside of work? Biking to get ice
cream with my husband and four
children, attempting to bake (often
unsuccessfully), gardening, and
playing piano.

